CD8A and neoplasm: This could be explained by antigen escape, a phenomenon where tumor cells lose or reduce expression of specific antigens in response to killing of antigen-expressing cancer cells by tumor antigen-specific CD8 + T cells, which is a known occurrence in patients treated with T-cell immunotherapies, such as CAR T-cell therapy [36, 37].